Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Editorial Reflects Conservative Approach To Use Of Drug-Eluting Stents

This article was originally published in The Gray Sheet

Executive Summary

As apprehension over the use of drug-eluting stents grows, two cardiologists last week fired another salvo, asserting that the overuse of DES is placing too many patients in harm's way for little or no added benefit

You may also be interested in...



U.S. DES Use Will Stabilize At Already Lowered Rates, Physicians Suggest

Recommendations by an FDA advisory panel earlier this month will likely reinforce, but not amplify, already moderated usage patterns of drug-eluting stents in the U.S., doctors suggest

U.S. DES Use Will Stabilize At Already Lowered Rates, Physicians Suggest

Recommendations by an FDA advisory panel earlier this month will likely reinforce, but not amplify, already moderated usage patterns of drug-eluting stents in the U.S., doctors suggest

Thrombosis Risk In Taxus And Cypher Is Real, TCT Data Shows; Now What?

With a growing consensus coming out of last week's Transcatheter Cardiovascular Therapeutics meeting that first-generation drug-eluting stents (DES) are associated with an increased long-term risk of blood clots, cardiologists are grappling with how use of these blockbuster products might need to be modified

Related Content

UsernamePublicRestriction

Register

MT024081

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel